Skip to main content
. 2022 May 21;10(5):1194. doi: 10.3390/biomedicines10051194

Table 5.

Description of the insertions, deletions, or combinations of both, identified by cloning/sequencing analysis in the 4 patients selected.

Patient
(N Clones Analyzed)
Deletions Insertions N Clones (%) ID N Reads (%)
2 (24) 1627 + 1758 − 1777 1647 TCTTACATAAGAGGACTCTTGGAC 12 (50) 12 9554 (51.9)
- 1820 C 1 (4.2) 74 75 (0.4)
1627 + 1726 + 1758 − 1777 1647 TCTTACATAAGAGGACTCTTGGAC 2 (8) - -
1627 + 1758 − 1777 1647 TCTTACATAAGAGGACTCTTGGAC + 1822 ATTCAA + 1825 T 1 (4.2) - -
1627 1600T + 1647 TCTTACATAAGAGGACTCTTGGAC 1 (4.2) - -
- - 7 (29.2) - 4692 (25.5)
17 (29) - 1825 T 2 (6.9) 84 3140 (14.2)
- 1909 TG 1 (3.4) * *
- - 26 (89.7) - 18736 (84.8)
20 (18) 1825 - 1 (5.6) 85 3011 (15.5)
- 1826 TTC 6 (33.3) 89 2171 (11.2)
- - 11 (61) - 14064 (72.5)
39 (19) - 1605 T 1 (5.3) - -
- 1825 T 7 (36.8) 84 3242 (22.9)
- 1895 T 1 (5.3) * *
- - 10 (52.6) - 9701 (68.5)

Abbreviations: N Clones indicates number of clones showing a specific insertion, deletion or combination of both; ID, code to designate single insertion or deletion, or combinations of them identified by next-generation sequencing (see Table S3); N Reads, number of next-generation sequencing reads showing a specific single insertion or deletion, or a combination of both. * Insertions that have not been assessed in next-generation sequencing reads since they are located out of hepatitis B X gene open reading frame.